George Goldenfeld

Programmed inhibition of an innate immune receptor via de novo designed transmembrane proteins

Transmembrane domains of immune complexes transmit precise signals across lipid bilayers. Probing their interactions has the potential to yield mechanistic insights relevant to therapeutic design. However, our capability to generate molecules that bind lipid-embedded sites is lim...